BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 19591530)

  • 1. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.
    Golomb BA; Kwon EK; Koperski S; Evans MA
    Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and amyotrophic lateral sclerosis--the level of evidence for an association.
    Sørensen HT; Lash TL
    J Intern Med; 2009 Dec; 266(6):520-6. PubMed ID: 19930099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.
    Golomb BA; Verden A; Messner AK; Koslik HJ; Hoffman KB
    Drug Saf; 2018 Apr; 41(4):403-413. PubMed ID: 29427042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly.
    Freedman DM; Kuncl RW; Cahoon EK; Rivera DR; Pfeiffer RM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):538-546. PubMed ID: 31112080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.
    Golomb BA; McGraw JJ; Evans MA; Dimsdale JE
    Drug Saf; 2007; 30(8):669-75. PubMed ID: 17696579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
    Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.
    Su XW; Nandar W; Neely EB; Simmons Z; Connor JR
    Muscle Nerve; 2016 Aug; 54(2):284-91. PubMed ID: 26799243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.
    Golomb BA; Evans MA
    Am J Cardiovasc Drugs; 2008; 8(6):373-418. PubMed ID: 19159124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-associated muscle-related adverse effects: a case series of 354 patients.
    Cham S; Evans MA; Denenberg JO; Golomb BA
    Pharmacotherapy; 2010 Jun; 30(6):541-53. PubMed ID: 20500044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between statins and the risk of amyotrophic lateral sclerosis: A PRISMA-compliant meta-analysis.
    Chang MC; Kwak SG; Park JS; Park D
    Medicine (Baltimore); 2021 Jul; 100(30):e26751. PubMed ID: 34397718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Nabizadeh F; Balabandian M; Sharafi AM; Ghaderi A; Rostami MR; Naser Moghadasi A
    Acta Neurol Belg; 2022 Aug; 122(4):979-986. PubMed ID: 34322852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to overcome statin intolerance.
    Agouridis AP; Nair DR; Mikhailidis DP
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):851-5. PubMed ID: 25786568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins' effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation.
    Littlefield N; Beckstrand RL; Luthy KE
    J Am Assoc Nurse Pract; 2014 Feb; 26(2):85-90. PubMed ID: 24170646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the way, doctor. I take a statin. Should I be taking coenzyme Q(10) to protect myself against the muscle pain that statins can cause?
    Komaroff AL
    Harv Health Lett; 2010 Feb; 35(4):8. PubMed ID: 20376911
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality.
    Weisskopf MG; Levy J; Dickerson AS; Paganoni S; Leventer-Roberts M
    Am J Epidemiol; 2022 Jun; 191(7):1248-1257. PubMed ID: 35333291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Zheng Z; Sheng L; Shang H
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):241-5. PubMed ID: 23134508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do you treat patients with myalgia who take statins?
    Siddiqi SA; Thompson PD
    Curr Atheroscler Rep; 2009 Jan; 11(1):9-14. PubMed ID: 19080722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.
    Chaipichit N; Krska J; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2015 Apr; 37(2):355-64. PubMed ID: 25630895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.